Hirakata, Japan

Takuhiko Adachi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Foundation for Biomedical Research and Innovation, Keio University, Morishita Jintan Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuhiko Adachi. Retrieved from https://idiyas.com/inventor/takuhiko-adachi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takuhiko Adachi: Innovator in Ulcerative Colitis Treatment

Introduction

Takuhiko Adachi is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of ulcerative colitis. His innovative approach has led to the development of a unique capsule designed to enhance the effectiveness of treatment while minimizing side effects.

Latest Patents

One of Takuhiko Adachi's key inventions is a capsule for treating ulcerative colitis. This capsule is designed to disintegrate locally in the large intestine, which allows for more effective treatment compared to conventional methods. The capsule contains indigo, a drug known for its therapeutic properties against ulcerative colitis. The innovative design includes a protective layer and a film that ensures the capsule does not disintegrate until it reaches the large intestine, thereby reducing the risk of hepatotoxicity.

Career Highlights

Throughout his career, Takuhiko Adachi has worked with prestigious institutions such as Keio University and the Foundation for Biomedical Research and Innovation at Kobe. His work has been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Takuhiko Adachi has collaborated with notable colleagues, including Takanori Kanai and Hideo Nishimura. These partnerships have contributed to the development and refinement of his innovative medical solutions.

Conclusion

Takuhiko Adachi's contributions to the treatment of ulcerative colitis through his patented capsule demonstrate his commitment to medical innovation. His work continues to impact the field positively, offering hope for improved treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…